New drug selonabant put to the test in healthy volunteers
NCT ID NCT07211607
First seen Oct 31, 2025 · Last updated May 11, 2026 · Updated 23 times
Summary
This early-stage study tested a single dose of the drug selonabant in 40 healthy adults aged 18 to 30. The main goal was to check for side effects and see how the body processes the drug. Participants received either the drug or a placebo, and researchers monitored their health closely. This trial does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Austin Clinical Research Unit
Austin, Texas, 78744, United States
Conditions
Explore the condition pages connected to this study.